{"id":707699,"date":"2026-08-17T07:30:44","date_gmt":"2026-08-16T23:30:44","guid":{"rendered":"https:\/\/law.asia\/?p=707699"},"modified":"2026-08-13T16:41:50","modified_gmt":"2026-08-13T08:41:50","slug":"ingenia-therapeutics-ipo-korea","status":"publish","type":"post","link":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/","title":{"rendered":"\ubbf8\uad6d \ubc14\uc774\uc624 \uae30\uc5c5 \uc778\uc81c\ub2c8\uc544\uc758 \ucf54\uc2a4\ub2e5 \uc0c1\uc7a5\uc5d0 \ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591 \uc790\ubb38"},"content":{"rendered":"<p>\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591\uc774 \ubc14\uc774\uc624\ud14c\ud06c \uae30\uc5c5 Ingenia Therapeutics\uc758 \ucf54\uc2a4\ub2e5 \uae30\uc5c5\uacf5\uac1c(IPO)\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. Ingenia Therapeutics\ub294 \uc624\ub294 18\uc77c \ubbf8\uad6d \uae30\ubc18 \uae30\uc5c5\uc758 \ud55c\uad6d \ucd5c\ucd08 \uc0c1\uc7a5\uc778 \uc774\ubc88 IPO\ub97c \ud1b5\ud574 600\uc5b5\uc6d0\uc744 \uc870\ub2ec\ud560 \uc608\uc815\uc774\ub2e4.<\/p>\n<p>Ingenia Therapeutics\ub294 \uc8fc\ub2f9 1\ub9cc 2,000\uc6d0\uc5d0 \ud55c\uad6d\uc608\ud0c1\uc99d\uc11c(KDR) 500\ub9cc\uc8fc\ub97c \uacf5\ubaa8\ud55c\ub2e4. KDR\uc740 \ubbf8\uad6d \ubcf4\ud1b5\uc8fc\uc640 1\ub3001 \ube44\uc728\ub85c \ubc1c\ud589\ub418\uba70, \ucd5c\uc885 \uacf5\ubaa8\uac00\ub294 \ud76c\ub9dd \uacf5\ubaa8\uac00 \ubc94\uc704\uc778 1\ub9cc 2,000~1\ub9cc 4,500\uc6d0\uc758 \ud558\ub2e8\uc778 1\ub9cc 2,000\uc6d0\uc73c\ub85c \uacb0\uc815\ub410\ub2e4. \uc774\uc5d0 \ub530\ub77c \ucd1d \uacf5\ubaa8\uae08\uc561\uc740 600\uc5b5\uc6d0, \uc0c1\uc7a5 \ud6c4 \uc2dc\uac00\ucd1d\uc561\uc740 6,420\uc5b5\uc6d0\uc73c\ub85c \uc608\uc0c1\ub41c\ub2e4.<\/p>\n<p>\ud0dc\ud3c9\uc591 \uc790\ubb38\ud300\uc744 \uc774\ub048 \ud604\uc608\ub9bc \ud30c\ud2b8\ub108 \ubcc0\ud638\uc0ac\ub294 <em>Asia Business Law Journal<\/em>\uc5d0 \u201c\uc774\ubc88 IPO\ub294 \uc57d 5\ub144 6\uac1c\uc6d4\ub9cc\uc5d0 \uc774\ub904\uc9c0\ub294 \ubbf8\uad6d \uae30\uc5c5\uc758 \ud55c\uad6d\uac70\ub798\uc18c \uc0c1\uc7a5 \uc0ac\ub840\u201d\ub77c\uace0 \ub9d0\ud588\ub2e4.<\/p>\n<p>\ud604 \ubcc0\ud638\uc0ac\ub294 \uadf8 \uc0ac\uc774\uc5d0\ub3c4 \ubbf8\uad6d \uae30\uc5c5\ub4e4\uc774 \ud55c\uad6d\uac70\ub798\uc18c \uc0c1\uc7a5\uc744 \uc2e0\uccad\ud558\uace0 \uc2ec\uc0ac\ub97c \ubc1b\uc740 \uc0ac\ub840\ub294 \uc788\uc5c8\uc9c0\ub9cc, \uc2e4\uc81c\ub85c \uc0c1\uc7a5 \uc2b9\uc778\uc744 \ubc1b\uc544 \uc815\uc2dd \uc0c1\uc7a5\uae4c\uc9c0 \uc774\uc5b4\uc9c4 \uc0ac\ub840\uac00 \uc5c6\uc5c8\ub2e4\uace0 \ubc1d\ud614\ub2e4. \uc774\uc5b4 \uc774\ubc88 \uc0c1\uc7a5\uc740 \uc624\ub79c \uae30\uac04 \uc911\ub2e8\ub3fc \uc788\ub358 \ubbf8\uad6d \uae30\uc5c5\uc758 \uad6d\ub0b4 \uc0c1\uc7a5 \ud2b8\ub799\uc774 \ub2e4\uc2dc \uc774\uc5b4\uc84c\ub2e4\ub294 \uc810\uc5d0\uc11c \uc758\ubbf8\uac00 \ud06c\ub2e4\uace0 \ub9d0\ud588\ub2e4.<\/p>\n<p>\ud0dc\ud3c9\uc591\uc740 Ingenia Therapeutics\uc5d0 \uc0c1\uc7a5 \uad00\ub828 \uc77c\ubc18 \ubc95\ub960 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. \uc5ec\uae30\uc5d0\ub294 \ubc1c\ud589\ud68c\uc0ac\uc758 \ud55c\uad6d\uac70\ub798\uc18c \uc0c1\uc7a5 \uad00\ub828 \uad6d\ub0b4 \uad00\ub828 \ubc95\uaddc \uac80\ud1a0, \ud55c\uad6d\ubc95 \uad00\uc810\uc5d0\uc11c \uc0c1\uc7a5 \uad6c\uc870 \uac80\ud1a0, \ud55c\uad6d\ubc95\uc801\uc778 \uc601\ud5a5\uc774 \uc788\ub294 \uacc4\uc57d\uc11c \uc2e4\uc0ac \ubc0f \uac70\ub798 \uad6c\uc870 \uac80\ud1a0 \ub4f1\uc758 \uc5c5\ubb34\uac00 \ud3ec\ud568\ub410\ub2e4. \ud604 \ubcc0\ud638\uc0ac\ub294 \uc2e0\ud76c\uac15 \ud30c\ud2b8\ub108 \ubcc0\ud638\uc0ac\uc640 \ud568\uaed8 \ud0dc\ud3c9\uc591 \uc790\ubb38\ud300\uc744 \uacf5\ub3d9\uc73c\ub85c \uc774\ub04c\uc5c8\ub2e4.<\/p>\n<p>\ud604 \ubcc0\ud638\uc0ac\ub294 \u201c\uad6d\ub0b4 \uae30\uc5c5\uc758 \uc77c\ubc18\uc801\uc778 IPO\uc640 \ub2ec\ub9ac \ud55c\uad6d\uc758 \uc0c1\uc7a5\u00b7\uacf5\uc2dc \uaddc\uc81c\ubfd0 \uc544\ub2c8\ub77c \ubbf8\uad6d \ud68c\uc0ac\ubc95 \ubc0f \uc99d\uad8c\ubc95\uc0c1 \uc694\uac74\uc744 \ud568\uaed8 \uace0\ub824\ud558\uc5ec \uac70\ub798 \uad6c\uc870\uc640 \uc0c1\uc7a5 \uc900\ube44 \uc808\ucc28\ub97c \uc124\uacc4\ud574\uc57c \ud588\ub2e4\u201d\uace0 \ub9d0\ud588\ub2e4.<\/p>\n<p>\uc774\uc5b4 \ubbf8\uad6d\ubc95\uc744 \uae30\ubc18\uc73c\ub85c \uc6b4\uc601\ub3fc \uc628 \ud68c\uc0ac\uc758 \uc9c0\ubc30\uad6c\uc870, \uc790\ubcf8\uad6c\uc870 \ubc0f \uc8fc\uc2dd\ubcf4\uc0c1\uc81c\ub3c4\ub97c \ud55c\uad6d\uac70\ub798\uc18c\uc758 \uc678\uad6d\uae30\uc5c5 \uc0c1\uc7a5\uc2ec\uc0ac \uae30\uc900\uacfc \uc870\ud654\uc2dc\ud0a4\ub294 \uc791\uc5c5\uc774 \uc911\uc694\ud588\ub2e4\uace0 \ub367\ubd99\uc600\ub2e4.<\/p>\n<p>\uc774\ubc88 IPO\uc758 \ubbf8\uad6d \uad00\ub828 \uc5c5\ubb34\ub294 Greenberg Traurig\uc758 \uc8fc\uc8fc \ubcc0\ud638\uc0ac\uc778 Justin MANN, Nathan EMERITZ, Pallav RAGHUVANSHI, Christopher GOTTFRIED, Matthew LEVINSTEIN \ubc0f Jason SIMON \ub4f1\uc774 \ub2f4\ub2f9\ud588\ub2e4.<\/p>\n<p>\ud604 \ubcc0\ud638\uc0ac\ub294 \uc774\ubc88 \uac70\ub798\uac00 \ud5a5\ud6c4 \ud574\uc678 \uae30\uc5c5\ub4e4\uc774 \ud55c\uad6d \uc790\ubcf8\uc2dc\uc7a5\uc744 \uc0c1\uc7a5 \uc2dc\uc7a5 \uc911 \ud558\ub098\ub85c \uac80\ud1a0\ud558\ub294 \ub370 \uae0d\uc815\uc801\uc778 \uc120\ub840\uac00 \ub420 \uc218 \uc788\uae30\ub97c \uae30\ub300\ud55c\ub2e4\uace0 \ubc1d\ud614\ub2e4.<\/p>\n<p>\uadf8\ub294 \u201c\ubc95\ub960\uc801\uc73c\ub85c \uc608\uce21 \uac00\ub2a5\ud55c \uc0c1\uc7a5\uacbd\ub85c\uc640 \uc2dc\uc7a5\uc758 \uc790\uae08\uc870\ub2ec \uae30\ub2a5\uc774 \ud568\uaed8 \ud655\uc778\ub41c\ub2e4\uba74, \ud55c\uad6d \uc790\ubcf8\uc2dc\uc7a5\uc740 \uc678\uad6d\uae30\uc5c5\uc5d0\uac8c\ub3c4 \ubcf4\ub2e4 \uc2e4\uc9c8\uc801\uc778 \ud30c\uc774\ub0b8\uc2f1 \uc635\uc158\uc774 \ub420 \uc218 \uc788\uc73c\uba70, \ud55c\uad6d \uc790\ubcf8\uc2dc\uc7a5\ub3c4 \uad6d\ub0b4 \uae30\uc5c5 \uc77c\ubcc0\ub3c4\uc5d0\uc11c \ubc97\uc5b4\ub098\uc11c \uad6d\uc81c\ud654\ub418\uace0 \uc120\uc9c4\ud654\ub418\ub294 \ubc29\ud5a5\uc73c\ub85c \ub098\uc544\uac08 \uc218 \uc788\ub2e4\u201d\uace0 \ub9d0\ud588\ub2e4.<\/p>\n<p>Ingenia Therapeutics\ub294 \uc0c1\ub2f9\ud55c \ubbf8\ucda9\uc871 \uc758\ub8cc \uc218\uc694\uac00 \uc874\uc7ac\ud558\ub294 \ubbf8\uc138\ud608\uad00 \uc9c8\ud658\uc744 \ub300\uc0c1\uc73c\ub85c \ud45c\uc801 \ud56d\uc81c \uce58\ub8cc\uc81c\ub97c \uac1c\ubc1c\ud558\ub294 \ub370 \uc8fc\ub825\ud558\uace0 \uc788\ub2e4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591\uc774 \ubc14\uc774\uc624\ud14c\ud06c \uae30\uc5c5 Ingenia Therapeutics\uc758 \ucf54\uc2a4\ub2e5 \uae30\uc5c5\uacf5\uac1c(IPO)\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. Ingenia Therapeutics\ub294 \uc624\ub294 18\uc77c \ubbf8\uad6d \uae30\ubc18 \uae30\uc5c5\uc758 \ud55c\uad6d \ucd5c\ucd08 \uc0c1\uc7a5\uc778 \uc774\ubc88 IPO\ub97c \ud1b5\ud574 600\uc5b5\uc6d0\uc744 \uc870\ub2ec\ud560 \uc608\uc815\uc774\ub2e4. Ingenia Therapeutics\ub294 \uc8fc\ub2f9 1\ub9cc<\/p>\n","protected":false},"author":13501,"featured_media":707631,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","meta-author":"","footnotes":""},"categories":[8398,8532],"tags":[194004,114980,180564,193155,116960,148801,116957,105318,159809,142571,156726,194001,128818,127038,162718,157638,121941,184241,194002,194003,138527],"class_list":["post-707699","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kr","category-8532","tag-ingenia-therapeutics-ko","tag-ipo-ko","tag-kdr","tag-united-states-ko","tag-116960","tag-148801","tag-116957","tag-105318","tag-159809","tag-142571","tag-156726","tag-194001","tag-128818","tag-127038","tag-162718","tag-157638","tag-121941","tag-184241","tag-194002","tag-194003","tag-138527"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.7 (Yoast SEO v17.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"description\" content=\"\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591\uc774 \ubc14\uc774\uc624\ud14c\ud06c \uae30\uc5c5 Ingenia Therapeutics\uc758 \ucf54\uc2a4\ub2e5 \uae30\uc5c5\uacf5\uac1c(IPO)\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. Ingenia Therapeutics\ub294 \uc624\ub294 18\uc77c \ubbf8\uad6d \uae30\ubc18 \uae30\uc5c5\uc758 \ud55c\uad6d \ucd5c\ucd08 \uc0c1\uc7a5\uc778 \uc774\ubc88 IPO\ub97c \ud1b5\ud574 600\uc5b5\uc6d0\uc744...\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ubbf8\uad6d \ubc14\uc774\uc624 \uae30\uc5c5 \uc778\uc81c\ub2c8\uc544\uc758 \ucf54\uc2a4\ub2e5 \uc0c1\uc7a5\uc5d0 \ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591 \uc790\ubb38\" \/>\n<meta property=\"og:description\" content=\"\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591\uc774 \ubc14\uc774\uc624\ud14c\ud06c \uae30\uc5c5 Ingenia Therapeutics\uc758 \ucf54\uc2a4\ub2e5 \uae30\uc5c5\uacf5\uac1c(IPO)\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. Ingenia Therapeutics\ub294 \uc624\ub294 18\uc77c \ubbf8\uad6d \uae30\ubc18 \uae30\uc5c5\uc758 \ud55c\uad6d \ucd5c\ucd08 \uc0c1\uc7a5\uc778 \uc774\ubc88 IPO\ub97c \ud1b5\ud574 600\uc5b5\uc6d0\uc744...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/\" \/>\n<meta property=\"og:site_name\" content=\"Law.asia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-16T23:30:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T08:41:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:site\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Website team 05\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\ubd84\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#organization\",\"name\":\"Law.asia\",\"url\":\"https:\/\/law-asia.visibleone.dev\/ko\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\",\"https:\/\/www.instagram.com\/law.asia_\/?hl=en\",\"https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/\",\"https:\/\/www.youtube.com\/@Law.asiaLimited\",\"https:\/\/twitter.com\/ablj_insights\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#logo\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"contentUrl\":\"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"width\":152,\"height\":152,\"caption\":\"Law.asia\"},\"image\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#website\",\"url\":\"https:\/\/law-asia.visibleone.dev\/ko\/\",\"name\":\"Law.asia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/law-asia.visibleone.dev\/ko\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ko-KR\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#primaryimage\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg\",\"contentUrl\":\"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg\",\"width\":900,\"height\":600,\"caption\":\"Ingenia Therapeutics IPO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#webpage\",\"url\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/\",\"name\":\"\\ubbf8\\uad6d \\ubc14\\uc774\\uc624 \\uae30\\uc5c5 \\uc778\\uc81c\\ub2c8\\uc544\\uc758 \\ucf54\\uc2a4\\ub2e5 \\uc0c1\\uc7a5\\uc5d0 \\ubc95\\ubb34\\ubc95\\uc778 \\ud0dc\\ud3c9\\uc591 \\uc790\\ubb38 | Law.asia\",\"isPartOf\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#primaryimage\"},\"datePublished\":\"2026-08-16T23:30:44+00:00\",\"dateModified\":\"2026-08-13T08:41:50+00:00\",\"description\":\"\\ubc95\\ubb34\\ubc95\\uc778 \\ud0dc\\ud3c9\\uc591\\uc774 \\ubc14\\uc774\\uc624\\ud14c\\ud06c \\uae30\\uc5c5 Ingenia Therapeutics\\uc758 \\ucf54\\uc2a4\\ub2e5 \\uae30\\uc5c5\\uacf5\\uac1c(IPO)\\uc5d0 \\uc790\\ubb38\\uc744 \\uc81c\\uacf5\\ud588\\ub2e4. Ingenia Therapeutics\\ub294 \\uc624\\ub294 18\\uc77c \\ubbf8\\uad6d \\uae30\\ubc18 \\uae30\\uc5c5\\uc758 \\ud55c\\uad6d \\ucd5c\\ucd08 \\uc0c1\\uc7a5\\uc778 \\uc774\\ubc88 IPO\\ub97c \\ud1b5\\ud574 600\\uc5b5\\uc6d0\\uc744...\",\"breadcrumb\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#breadcrumb\"},\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\"}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#webpage\"},\"author\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#\/schema\/person\/5622fa84f077484b1195f2f445d9b8e9\"},\"headline\":\"\\ubbf8\\uad6d \\ubc14\\uc774\\uc624 \\uae30\\uc5c5 \\uc778\\uc81c\\ub2c8\\uc544\\uc758 \\ucf54\\uc2a4\\ub2e5 \\uc0c1\\uc7a5\\uc5d0 \\ubc95\\ubb34\\ubc95\\uc778 \\ud0dc\\ud3c9\\uc591 \\uc790\\ubb38\",\"datePublished\":\"2026-08-16T23:30:44+00:00\",\"dateModified\":\"2026-08-13T08:41:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#webpage\"},\"wordCount\":35,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#organization\"},\"image\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg\",\"keywords\":[\"Ingenia Therapeutics\",\"IPO\",\"KDR\",\"United States\",\"\\uae30\\uc5c5\\uacf5\\uac1c\",\"\\ub300\\ud55c\\ubbfc\\uad6d\",\"\\ubbf8\\uad6d\",\"\\ubc95\\ubb34\\ubc95\\uc778 \\ud0dc\\ud3c9\\uc591\",\"\\ubcf4\\ud1b5\\uc8fc\",\"\\uc0c1\\uc7a5\",\"\\uc2dc\\uac00\\ucd1d\\uc561\",\"\\uc2e0\\ud76c\\uac15\",\"\\uc790\\ubcf8\\uc2dc\\uc7a5\",\"\\uc99d\\uad8c\\ubc95\",\"\\ucf54\\uc2a4\\ub2e5\",\"\\ud0dc\\ud3c9\\uc591\",\"\\ud55c\\uad6d\",\"\\ud55c\\uad6d\\uac70\\ub798\\uc18c\",\"\\ud55c\\uad6d\\uc608\\ud0c1\\uc99d\\uc11c\",\"\\ud604\\uc608\\ub9bc\",\"\\ud68c\\uc0ac\\ubc95\"],\"articleSection\":[\"Asia Business Law Journal\",\"\\ub274\\uc2a4\"],\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\/\/law-asia.visibleone.dev\/#organization\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#\/schema\/person\/5622fa84f077484b1195f2f445d9b8e9\",\"name\":\"Website team 05\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law-asia.visibleone.dev\/ko\/#personlogo\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g\",\"caption\":\"Website team 05\"},\"url\":\"https:\/\/law-asia.visibleone.dev\/ko\/author\/johnmanson\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"description":"\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591\uc774 \ubc14\uc774\uc624\ud14c\ud06c \uae30\uc5c5 Ingenia Therapeutics\uc758 \ucf54\uc2a4\ub2e5 \uae30\uc5c5\uacf5\uac1c(IPO)\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. Ingenia Therapeutics\ub294 \uc624\ub294 18\uc77c \ubbf8\uad6d \uae30\ubc18 \uae30\uc5c5\uc758 \ud55c\uad6d \ucd5c\ucd08 \uc0c1\uc7a5\uc778 \uc774\ubc88 IPO\ub97c \ud1b5\ud574 600\uc5b5\uc6d0\uc744...","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"ko_KR","og_type":"article","og_title":"\ubbf8\uad6d \ubc14\uc774\uc624 \uae30\uc5c5 \uc778\uc81c\ub2c8\uc544\uc758 \ucf54\uc2a4\ub2e5 \uc0c1\uc7a5\uc5d0 \ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591 \uc790\ubb38","og_description":"\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591\uc774 \ubc14\uc774\uc624\ud14c\ud06c \uae30\uc5c5 Ingenia Therapeutics\uc758 \ucf54\uc2a4\ub2e5 \uae30\uc5c5\uacf5\uac1c(IPO)\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. Ingenia Therapeutics\ub294 \uc624\ub294 18\uc77c \ubbf8\uad6d \uae30\ubc18 \uae30\uc5c5\uc758 \ud55c\uad6d \ucd5c\ucd08 \uc0c1\uc7a5\uc778 \uc774\ubc88 IPO\ub97c \ud1b5\ud574 600\uc5b5\uc6d0\uc744...","og_url":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/","og_site_name":"Law.asia","article_publisher":"https:\/\/www.facebook.com\/AsiaBusinessLaw\/","article_published_time":"2026-08-16T23:30:44+00:00","article_modified_time":"2026-08-13T08:41:50+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@ablj_insights","twitter_site":"@ablj_insights","twitter_misc":{"Written by":"Website team 05","Est. reading time":"2\ubd84"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/law-asia.visibleone.dev\/ko\/#organization","name":"Law.asia","url":"https:\/\/law-asia.visibleone.dev\/ko\/","sameAs":["https:\/\/www.facebook.com\/AsiaBusinessLaw\/","https:\/\/www.instagram.com\/law.asia_\/?hl=en","https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/","https:\/\/www.youtube.com\/@Law.asiaLimited","https:\/\/twitter.com\/ablj_insights"],"logo":{"@type":"ImageObject","@id":"https:\/\/law-asia.visibleone.dev\/ko\/#logo","inLanguage":"ko-KR","url":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","contentUrl":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","width":152,"height":152,"caption":"Law.asia"},"image":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/#logo"}},{"@type":"WebSite","@id":"https:\/\/law-asia.visibleone.dev\/ko\/#website","url":"https:\/\/law-asia.visibleone.dev\/ko\/","name":"Law.asia","description":"","publisher":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/law-asia.visibleone.dev\/ko\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ko-KR"},{"@type":"ImageObject","@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#primaryimage","inLanguage":"ko-KR","url":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg","contentUrl":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg","width":900,"height":600,"caption":"Ingenia Therapeutics IPO"},{"@type":"WebPage","@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#webpage","url":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/","name":"\ubbf8\uad6d \ubc14\uc774\uc624 \uae30\uc5c5 \uc778\uc81c\ub2c8\uc544\uc758 \ucf54\uc2a4\ub2e5 \uc0c1\uc7a5\uc5d0 \ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591 \uc790\ubb38 | Law.asia","isPartOf":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/#website"},"primaryImageOfPage":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#primaryimage"},"datePublished":"2026-08-16T23:30:44+00:00","dateModified":"2026-08-13T08:41:50+00:00","description":"\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591\uc774 \ubc14\uc774\uc624\ud14c\ud06c \uae30\uc5c5 Ingenia Therapeutics\uc758 \ucf54\uc2a4\ub2e5 \uae30\uc5c5\uacf5\uac1c(IPO)\uc5d0 \uc790\ubb38\uc744 \uc81c\uacf5\ud588\ub2e4. Ingenia Therapeutics\ub294 \uc624\ub294 18\uc77c \ubbf8\uad6d \uae30\ubc18 \uae30\uc5c5\uc758 \ud55c\uad6d \ucd5c\ucd08 \uc0c1\uc7a5\uc778 \uc774\ubc88 IPO\ub97c \ud1b5\ud574 600\uc5b5\uc6d0\uc744...","breadcrumb":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#breadcrumb"},"inLanguage":"ko-KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home"}]},{"@type":"NewsArticle","@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#article","isPartOf":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#webpage"},"author":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/#\/schema\/person\/5622fa84f077484b1195f2f445d9b8e9"},"headline":"\ubbf8\uad6d \ubc14\uc774\uc624 \uae30\uc5c5 \uc778\uc81c\ub2c8\uc544\uc758 \ucf54\uc2a4\ub2e5 \uc0c1\uc7a5\uc5d0 \ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591 \uc790\ubb38","datePublished":"2026-08-16T23:30:44+00:00","dateModified":"2026-08-13T08:41:50+00:00","mainEntityOfPage":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#webpage"},"wordCount":35,"commentCount":0,"publisher":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/#organization"},"image":{"@id":"https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#primaryimage"},"thumbnailUrl":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2026\/08\/Ingenia-eyes-USD42m-IPO-as-first-US-company-listing-in-Korea.jpg","keywords":["Ingenia Therapeutics","IPO","KDR","United States","\uae30\uc5c5\uacf5\uac1c","\ub300\ud55c\ubbfc\uad6d","\ubbf8\uad6d","\ubc95\ubb34\ubc95\uc778 \ud0dc\ud3c9\uc591","\ubcf4\ud1b5\uc8fc","\uc0c1\uc7a5","\uc2dc\uac00\ucd1d\uc561","\uc2e0\ud76c\uac15","\uc790\ubcf8\uc2dc\uc7a5","\uc99d\uad8c\ubc95","\ucf54\uc2a4\ub2e5","\ud0dc\ud3c9\uc591","\ud55c\uad6d","\ud55c\uad6d\uac70\ub798\uc18c","\ud55c\uad6d\uc608\ud0c1\uc99d\uc11c","\ud604\uc608\ub9bc","\ud68c\uc0ac\ubc95"],"articleSection":["Asia Business Law Journal","\ub274\uc2a4"],"inLanguage":"ko-KR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/law-asia.visibleone.dev\/ko\/ingenia-therapeutics-ipo-korea\/#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/law-asia.visibleone.dev\/#organization"}},{"@type":"Person","@id":"https:\/\/law-asia.visibleone.dev\/ko\/#\/schema\/person\/5622fa84f077484b1195f2f445d9b8e9","name":"Website team 05","image":{"@type":"ImageObject","@id":"https:\/\/law-asia.visibleone.dev\/ko\/#personlogo","inLanguage":"ko-KR","url":"https:\/\/secure.gravatar.com\/avatar\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g","caption":"Website team 05"},"url":"https:\/\/law-asia.visibleone.dev\/ko\/author\/johnmanson\/"}]}},"_links":{"self":[{"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/posts\/707699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/users\/13501"}],"replies":[{"embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/comments?post=707699"}],"version-history":[{"count":0,"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/posts\/707699\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/media\/707631"}],"wp:attachment":[{"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/media?parent=707699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/categories?post=707699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/ko\/wp-json\/wp\/v2\/tags?post=707699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}